Uveal Malignant Melanoma: Prognostic Factors

Clinical Ophthalmic Oncology

Volumn , Issue , 2007, Pages 272-276

  Folberg, Robert ^a   Pe'er, Jacob ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865186409     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3167-3.50051-6     Document Type: Chapter

References (32)

1. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study COMS report no 1. Arch Ophthalmol 1990, 108:1268-1273.
2. Shammas HF, Blodi FC Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977, 95:63-69.
3. Kaiserman I, Anteby I, Chowers I, et al. Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma. Br J Ophthalmol 2004, 88:892-895.
4. Augsburger JJ, Gamel JW Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 1990, 66:1596-1600.
5. Char DH, Kroll S, Phillips TL Uveal melanoma: Growth rate and prognosis. Arch Ophthalmol 1997, 115:1014-1018.
6. Kaiserman I, Rosner M, Pe'er J Forecasting the prognosis of choroidal melanoma with an artificial neural network. Ophthalmology 2005, 112:1608-1611.
7. Folberg R, Salomao D, Grossniklaus HE, et al. Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. The Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 2003, 34:114-118.
8. Gamel JW, McLean I, Greenberg RA, et al. Objective assessment of the malignant potential of intraocular melanomas with standard microslides stained with hematoxylin-eosin. Hum Pathol 1985, 16:689-692.
9. Callender GR Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931, 36:131-142.
10. McLean IW, Zimmerman LE, Evans RM Reappraisal of Callender's spindle A type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol 1978, 86:557-564.
11. McLean IW, Sibug ME, Becker RL, et al. Uveal melanoma: the importance of large nucleoli in predicting patient outcome - an automated image analysis study. Cancer 1997, 79:982-988.
12. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993, 100:1389-1398.
13. McLean IW, Foster WD, Zimmerman LE Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977, 95:48-58.
14. Pe'er J, Gnessin H, Shargal Y, et al. PC-10 immunostaining of proliferating cell nuclear antigen (PCNA) in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups. Ophthalmology 1994, 101:56-62.
15. de la Cruz PO, Specht CS, McLean IW Lymphocytic infiltration in uveal malignant melanoma. Cancer 1990, 65:112-115.
16. Lin AY, Maniotis AJ, Valyi-Nagy K, et al. Distinguishing fibrovascular septa from vasculogenic mimicry patterns. Arch Pathol Lab Med 2005, 129:884-892.
17. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999, 155:739-752.
18. Clarijs R, Otte-Holler I, Ruiter DJ, et al. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci 2002, 43:912-918.
19. Foss AJ, Alexander RA, Jefferies LW, et al. Microvessel count predicts survival in uveal melanoma. Cancer Res 1996, 56:2900-2903.
20. Chen X, Maniotis AJ, Majumdar D, et al. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci 2002, 43:2533-2539.
21. Augsburger JJ, Shields JA, Folberg R, et al. Fine needle aspiration biopsy in the diagnosis of intraocular cancer. Cytologic-histologic correlations. Ophthalmology 1985, 92:39-49.
22. Char DH, Kroll SM, Stoloff A, et al. Cytomorphometry of uveal melanoma. Comparison of fine needle aspiration biopsy samples with histologic sections. Anal Quant Cytol Histol 1991, 13:293-299.
23. Gambrelle J, Labialle S, Dayan G, et al. Toward monosomy 3 as the main prognosis factor of uveal melanoma: current cytogenetic data. J Fr Ophtalmol 2004, 27:1061-1067.
24. Sisley K, Nichols C, Parsons MA, et al. Clinical applications of chromosome analysis, from fine needle aspiration biopsies, of posterior uveal melanomas. Eye 1998, 12:203-207.
25. Tschentscher F, Husing J, Holter T, et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003, 63:2578-2584.
26. Onken MD, Worley LA, Ehlers JP, et al. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004, 64:7205-7209.
27. Kadkol SS, Lin AY, Barak V, et al. Osteopontin expression and serum levels in metastatic uveal melanoma - a pilot study. Invest Ophthalmol Vis Sci 2006, 47:802-806.
28. Scholes AGM, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: Correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003, 44:1008-1011.
29. Onken MD, Lin AY, Worley LA, et al. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Am J Ophthalmol 2005, 140:748-749.
30. Mueller AJ, Bartsch DU, Folberg R, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998, 116:31-39.
31. Coleman DJ, Silverman RH, Rondeau MJ, et al. Noninvasive in vivo detection of prognostic indicators for high-risk uveal melanoma: Ultrasound parameter imaging. Ophthalmology 2004, 111:558-564.
32. Schaller UC, Bosserhoff AK, Neubauer AS, et al. Melanoma inhibitory activity: a novel serum marker for uveal melanoma. Melanoma Res 2002, 12:593-599.